BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29338761)

  • 1. Is total femoral replacement for non-oncologic and oncologic indications a safe procedure in limb preservation surgery? A single center experience of 22 cases.
    Toepfer A; Harrasser N; Petzschner I; Pohlig F; Lenze U; Gerdesmeyer L; von Eisenhart-Rothe R; Mühlhofer H; Suren C
    Eur J Med Res; 2018 Jan; 23(1):5. PubMed ID: 29338761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short- to long-term follow-up of total femoral replacement in non-oncologic patients.
    Toepfer A; Harrasser N; Petzschner I; Pohlig F; Lenze U; Gerdesmeyer L; Pförringer D; Toepfer M; Beirer M; Crönlein M; von Eisenhart-Rothe R; Mühlhofer H
    BMC Musculoskelet Disord; 2016 Dec; 17(1):498. PubMed ID: 27955655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distal femoral replacement with the MML system: a single center experience with an average follow-up of 86 months.
    Toepfer A; Harrasser N; Schwarz PR; Pohlig F; Lenze U; Mühlhofer HML; Gerdesmeyer L; von Eisenhart-Rothe R; Suren C
    BMC Musculoskelet Disord; 2017 May; 18(1):206. PubMed ID: 28532493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total femur replacement in non-oncologic indications: Functional and radiological outcomes from a French survey with a mean 6 years' follow-up.
    Putman S; Migaud H; Saragaglia D; Jenny JY; Dujardin F; Hue AG; Fiorenza F; Méric O; Bonnevialle P;
    Orthop Traumatol Surg Res; 2019 Jun; 105(4):591-598. PubMed ID: 31027981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different outcomes after proximal femoral replacement in oncologic and failed revision arthroplasty patients - a retrospective cohort study.
    Toepfer A; Straßer V; Ladurner A; Calek AK; Potocnik P; von Eisenhart-Rothe R
    BMC Musculoskelet Disord; 2021 Sep; 22(1):813. PubMed ID: 34551731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramedullary and total femur replacement in revision arthroplasty as a last limb-saving option: is there any benefit from the less invasive intramedullary replacement?
    Hoell S; Butschek S; Gosheger G; Dedy N; Dieckmann R; Henrichs M; Daniilidis K; Hardes J
    J Bone Joint Surg Br; 2011 Nov; 93(11):1545-9. PubMed ID: 22058309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Are the Long-term Results of MUTARS
    Bus MP; van de Sande MA; Fiocco M; Schaap GR; Bramer JA; Dijkstra PD
    Clin Orthop Relat Res; 2017 Mar; 475(3):708-718. PubMed ID: 26649558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High complication and revision rates after total femoral replacement: a retrospective single center analysis of indication, function, and complication.
    Graulich T; Steimer D; Zhang D; Omar M; Weber-Spickschen S; Krettek C; Panzica M
    Arch Orthop Trauma Surg; 2019 Jul; 139(7):913-920. PubMed ID: 30687872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revision Distal Femoral Arthroplasty With the Compress(®) Prosthesis Has a Low Rate of Mechanical Failure at 10 Years.
    Zimel MN; Farfalli GL; Zindman AM; Riedel ER; Morris CD; Boland PJ; Healey JH
    Clin Orthop Relat Res; 2016 Feb; 474(2):528-36. PubMed ID: 26394638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are Complications Associated With the Repiphysis(®) Expandable Distal Femoral Prosthesis Acceptable for Its Continued Use?
    Staals EL; Colangeli M; Ali N; Casanova JM; Donati DM; Manfrini M
    Clin Orthop Relat Res; 2015 Sep; 473(9):3003-13. PubMed ID: 25995179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LUMiC
    Bus MP; Szafranski A; Sellevold S; Goryn T; Jutte PC; Bramer JA; Fiocco M; Streitbürger A; Kotrych D; van de Sande MA; Dijkstra PD
    Clin Orthop Relat Res; 2017 Mar; 475(3):686-695. PubMed ID: 27020434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distal femoral reconstruction following failed total knee arthroplasty is accompanied with risk for complication and reduced joint function.
    Vertesich K; Puchner SE; Staats K; Schreiner M; Hipfl C; Kubista B; Holinka J; Windhager R
    BMC Musculoskelet Disord; 2019 Jan; 20(1):47. PubMed ID: 30704448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Role of a Modular Universal Tumour and Revision System (MUTARS®) in Lower Limb Endoprosthetic Revision Surgery - Outcome Analysis of 25 Patients].
    Schmolders J; Koob S; Schepers P; Gravius S; Wirtz DC; Burger C; Pennekamp PH; Strauss AC
    Z Orthop Unfall; 2017 Feb; 155(1):61-66. PubMed ID: 27632667
    [No Abstract]   [Full Text] [Related]  

  • 14. Megaprostheses in the Revision of Infected Total Hip Arthroplasty. Clinical Series and Literature Review.
    Artiaco S; Boggio F; Colzani G; Titolo P; Zoccola K; Bianchi P; Bellomo F
    Bull Hosp Jt Dis (2013); 2015 Dec; 73(4):229-32. PubMed ID: 26630464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Survivorship With Cementless Stems and Cortical Strut Allografts for Large Femoral Bone Defects in Revision THA.
    Kim YH; Park JW; Kim JS; Rastogi D
    Clin Orthop Relat Res; 2015 Sep; 473(9):2990-3000. PubMed ID: 26013152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Are the Functional Results and Complications With Long Stem Hemiarthroplasty in Patients With Metastases to the Proximal Femur?
    Peterson JR; Decilveo AP; O'Connor IT; Golub I; Wittig JC
    Clin Orthop Relat Res; 2017 Mar; 475(3):745-756. PubMed ID: 27052019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proximal femoral replacement in contemporary revision total hip arthroplasty for severe femoral bone loss: a review of outcomes.
    Viste A; Perry KI; Taunton MJ; Hanssen AD; Abdel MP
    Bone Joint J; 2017 Mar; 99-B(3):325-329. PubMed ID: 28249971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of failure and survival of total femoral endoprosthetic replacements.
    Medellin MR; Fujiwara T; Clark R; Stevenson JD; Parry M; Jeys L
    Bone Joint J; 2019 May; 101-B(5):522-528. PubMed ID: 31038993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rate of fracture in the cementless modular Extrême™ (Mark I) femoral prosthesis in revision total hip arthroplasty: 33 cases at more than 5 years' follow-up.
    Benoist J; Lambotte JC; Polard JL; Huten D
    Orthop Traumatol Surg Res; 2013 Dec; 99(8):915-21. PubMed ID: 24211127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative Outcomes of Total Femur Replacement in Oncologic and Nononcologic Patients: A Systematic Review of the Literature.
    Gonzalez MR; Inchaustegui ML; Layme J; Ruiz-Arellanos K; Larios F; Pretell-Mazzini J
    J Arthroplasty; 2024 Jun; 39(6):1624-1631.e2. PubMed ID: 38061400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.